跳至主要内容
临床试验/NCT07164742
NCT07164742招募中不适用

Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB PURE) A Randomized Multi-Centre Trial

Johns Hopkins University2 个研究点 分布在 1 个国家目标入组 690 人开始时间: 2026年3月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
690
试验地点
2
主要终点
Six-Minute Walk Test (6MWT) distance (meters)

研究概览

简要总结

Individual-level, unblinded randomized controlled trial of an 8-week (short arm) or 24-week (extended arm) pulmonary rehabilitation program, relative to standard of care, to prevent post-tuberculosis respiratory morbidity. Randomization will occur in a 1:1:1 ratio at the initiation of treatment.

详细描述

8 weeks (short arm) or 24 weeks (extended arm) of a pulmonary rehabilitation (PR) program, administered during TB treatment, comprising of exercise training, counselling and education, and airway clearance techniques.

Objectives:

  1. To compare the effectiveness of two home-based PR programs, administered during TB treatment, for preventing post-TB respiratory morbidity.
  2. To describe the intersection between clinic-level service organization, fidelity of intervention delivery, and change in client behavior for the two PR programs.
  3. To compare the costs, cost-effectiveness, and budget impact of the two different PR strategies implemented as a routine program.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age at least 18 years
  • Microbiologically confirmed (smear microscopy, GeneXpert or culture) pulmonary TB disease*
  • Not completed more than 2 weeks of TB treatment
  • Receiving TB care at the outpatient clinics at the TB PuRe study sites
  • Willingness to complete 48 weeks of study evaluations.
  • Access to a smartphone.

排除标准

  • Modified Medical Research Council score of 0 points (dyspnea only with strenuous exercise)
  • Multi or extensively drug-resistant TB disease*
  • Extrapulmonary TB disease at any clinical sites without pulmonary involvement
  • TB meningitis or TB of the spine
  • Symptomatic cardiovascular disease, including coronary artery disease, arrhythmias and congestive cardiac failure.
  • Karnofsky Score < 40 points
  • Any medical condition that prevents pulmonary rehabilitation eg: fracture of lower/upper limbs/pregnancy
  • Bronchodilators and/or corticosteroids inhaled or otherwise.

研究组 & 干预措施

Short Arm Intervention

Experimental

8 weeks (short arm) of a pulmonary rehabilitation (PR) program

干预措施: 8 week (short arm) Intervention - pulmonary rehabilitation (Behavioral)

Long Arm Intervention

Experimental

24 weeks (extended arm) of a pulmonary rehabilitation (PR) program

干预措施: 24 week (long arm) Intervention - pulmonary rehabilitation (Behavioral)

Standard of care

No Intervention

Standard TB treatment without specific pulmonary rehabilitation

结局指标

主要结局

Six-Minute Walk Test (6MWT) distance (meters)

时间窗: 48 weeks post enrollment

Mean distance compared between study arms

次要结局

  • Six minute walk test (6MWT) distance (meters)(8,16 & 24 weeks post enrollment)
  • Absolute percent change in Mean Six minute walk test (6MWT) distance(8,16, 24 & 48 weeks post enrollment)
  • Proportion of Participants with change in Six minute walk test (6MWT) distance (meters)(8,16, 24 & 48 weeks post enrollment)
  • St. George's Respiratory Questionnaire (SGRQ) score(8,16,24 & 48 weeks post enrollment)
  • Absolute change in score for St. George's Respiratory Questionnaire (SGRQ)(8,16,24 & 48 weeks post enrollment)
  • Proportion of participants with change in score for St. George's Respiratory Questionnaire (SGRQ)(8,16,24 & 48 weeks post enrollment)
  • Percent change in score for St. George's Respiratory Questionnaire (SGRQ)(8,16,24 & 48 weeks post enrollment)
  • Percent Change in Chronic Respiratory Disease Questionnaire (CRQ) Dyspnea score(8,16,24 & 48 weeks post enrollment)
  • Modified Medical Research Council (mMRC) Dyspnoea Scale(8,16,24 & 48 weeks post enrollment)
  • Absolute change in the Modified Medical Research Council (mMRC) Dyspnoea Scale(8,16,24 & 48 weeks post enrollment)
  • Percent change in the Modified Medical Research Council (mMRC) Dyspnoea Scale(8,16,24 & 48 weeks post enrollment)
  • Proportion of participants with change in Modified Medical Research Council (mMRC) Dyspnoea Scale(8,16,24 & 48 weeks post enrollment)
  • Chronic Respiratory Disease Questionnaire (CRQ) Dyspnea score(8,16,24 & 48 weeks post enrollment)
  • Absolute change in Chronic Respiratory Disease Questionnaire (CRQ) Dyspnea score(8,16,24 & 48 weeks post enrollment)
  • Proportion of participants with change in Chronic Respiratory Disease Questionnaire (CRQ) Dyspnea sore(8,16,24 & 48 weeks post enrollment)
  • COPD Assessment Test (CAT) score(8,16,24 & 48 weeks post enrollment)
  • Absolute change in COPD Assessment Test (CAT) score(8,16,24 & 48 weeks post enrollment)
  • Percent change in COPD Assessment Test (CAT) score(8,16,24 & 48 weeks post enrollment)
  • Proportion of participants with a change in COPD Assessment Test (CAT) score(8,16,24 & 48 weeks post enrollment)
  • FEV1 volume (mL) - Lung function(24 & 48 weeks post enrollment)
  • Absolute change in FEV1 volume (mL) - Lung function(8, 16, 24 & 48 weeks post enrollment)
  • Percent change in FEV1 volume (mL) - Lung function(8, 16, 24 & 48 weeks post enrollment)
  • Proportion of participants with change in FEV1 and/or FVC volume (mL) - Lung function(8, 16, 24 & 48 weeks post enrollment)
  • FVC volume (mL) - Lung function(24 & 48 weeks post enrollment)
  • Absolute change in FVC volume (mL) - Lung function (FEV1 and FVC)(8,16, 24 & 48 weeks post enrollment)
  • Percent change in FVC volume (mL) - Lung function (FEV1 and FVC)(8,16, 24 & 48 weeks post enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验